BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Male Breast Cancer Global Alliance - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Male Breast Cancer Global Alliance
X-ORIGINAL-URL:https://mbcglobalalliance.org
X-WR-CALDESC:Events for The Male Breast Cancer Global Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231104T093000
DTEND;TZID=America/New_York:20231104T180000
DTSTAMP:20260417T102333
CREATED:20230816T114902Z
LAST-MODIFIED:20231101T221026Z
UID:4449-1699090200-1699120800@mbcglobalalliance.org
SUMMARY:MBCGA Annual Conference
DESCRIPTION:The Annual Male Breast Cancer Global Alliance Conference brings together male survivors\, their families\, friends and supporters with top medical professionals and leading experts from the breast cancer research and oncology fields. The international conference\, which focuses on increasing awareness and education about breast cancer in men\, showcases the latest in research developments and clinical trials with an impressive line-up of speakers from leading organizations around the world. Join us for this “virtual” day of sharing\, learning and camaraderie! \n			\n						Register\n					 \nMBCGA 2023 CONFERENCE SPEAKERS\n\n																										 \nOliver Bogler\, PhD\, Breast Cancer Survivor\, Director\, NCI Center for Cancer Training inBethesda\, MD \nDr. Bogler was diagnosed with Stage III cancer in 2012 while working as a cancer biologist at the University of Texas MD Anderson Cancer Center. He completed active treatment in 2013 and has participated in several clinical trials. Dr. Bogler is currently the Director of the Center for Cancer Training at the National Cancer Institute (NCI) in Bethesda\, MD. \nRead more \n																										 \nFatima Cardoso\, MD\, Director\, Breast Unit\, Champalimaud Clinical Center in Lisbon\, Portugal \nDr. Cardoso is actively involved in many Stage I-IV breast cancer clinical trials and is deeply involved in the field of cancer policy\, accessibility\, and inequalities. She is the Founder and President of the Advanced Breast Cancer (ABC) Global Alliance\, as well as the Founder and Chair of the ABC International Consensus Guidelines Conference.  \nRead more \n																										 \nSharon Giordano\, MD\, MPH\, FASCO\, Colin Powell Chair for Cancer Research; Chair\, Department of Health Services Research; Professor of Medicine\, Department of Breast Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston\, TX \nDr. Giordano is a medical oncologist specializing in the care of patients with breast cancer. Her work focuses on quality of health care delivery\, disparities\, outcomes for breast cancer patients\, late effects of treatment\, and male breast cancer. \nRead more \n																										 \nJosé Pablo Leone\, MD\, Director\, Program for Breast Cancer in MenAssistant Professor of Medicine\, Harvard Medical School\, Dana-Farber Cancer Institute\, Boston\, MA \nDr. Leone’s clinical research focuses on brain metastases\, male breast cancer and novel therapies in the treatment of breast cancer; he has co-authored 58 peer-reviewed articles and participated in 3 clinical trials in the past 15 years. \nRead more \n																										 \nKara N. Maxwell\, MD\, PhD\, Assistant Professor of Medicine & Genetics\, Perelman School of Medicine\, University of Pennsylvania; Staff Physician\, Corporal Michael Crescenz VA Medical Center\, Philadelphia\, PA \n Dr. Maxwell is the Director of the Men and BRCA Program within the Basser Center for BRCA at Penn Medicine and also the Director of the Cancer Genetics program at the Philadelphia VA.  \nRead more \n																										 \nIngrid A. Mayer\, MD\, MSCI; Vice President\, Global Clinical Strategy Head – Women’s Cancers\, AstraZeneca Late Development Oncology\, Gaithersburg\, Maryland \nDr. Mayer’s role is to pioneer and expand novel translational global research and innovative clinical trial development in breast cancer that accelerates the approval of established and novel drugs in the key areas of excellence at AstraZeneca\, tumor resistance/targeted therapies\, DNA damage response\, antibody-drug conjugates\, and immuno-oncology.  \nRead more \n																										 \nDr. Nick Orr\, PhD\, School of Medicine\, Dentistry and Biomedical Sciences\, Patrick G. Johnston Centre for Cancer Research at Queen’s University in Belfast\, Ireland \nDr. Orr is the Lead Researcher for a new international consortium working to uncover genes that lead to breast cancer in men. \nRead more \n																										 \nBen H. Park\, MD\, PhD\, Director\, Vanderbilt-Ingram Cancer Center\, Cornelius Abernathy Craig Chair\, Professor of Medicine\, Division of Hematology/Oncology\, Vanderbilt University Medical Center in Nashville\, TN \nDr. Park is an internationally renowned physician\, scientist\, and breast cancer expert with a specialty in male breast cancer research and clinical care of men with breast cancer. \nRead more \n																										 \nCarolien Schröder\, MD\, PhD\, Staff Member\, Medical Oncology\, Department\, Antoni Van Leeuwenhoek-Netherlands Cancer Institute\, Amsterdam\, The Netherlands \nDr. Schröder’s research is focused on pre-clinical and clinical intervention strategies directed at the breast cancer microenvironment and metastases\, early clinical trials with novel anticancer agents\, and large-scale registration and translational trials for rare subgroups including male and inflammatory breast cancer. \nRead more \n																										 \nMatthew Ellis\, MD\, BChir\, PhD\, FRCP\, Senior Vice President\, Early Oncology\, Oncology R&D\, AstraZeneca. \nDr. Ellis is a world-renowned clinician and researcher of the molecular profiling of breast cancer who leads a global community of over 1000 scientists working to bring the next wave of oncology medicines from target identification and into the clinic. \nRead more \n			\n						Download the 2023 MBCGA Conference Agenda & Schedule\n					 \nALL are welcome to attend our 2023 MBCGA Virtual Conference free of charge. However\, your donation (no amount is too small!) will help us to continue increasing awareness and providing the most up-to-date information on breast cancer in men\, advances in research and treatments\, and opportunities for clinical trials\, on a global scale. Thank you for your support! \n\n\n\n    \n        \n        \n        \n        \n        \n        \n        \n    \n\n\n\nThank you to our 2023 MBCGA Virtual Conference sponsors.
URL:https://mbcglobalalliance.org/event/mbcga-annual-conference-virtual-saturday-november-4/
ATTACH;FMTTYPE=image/png:https://mbcglobalalliance.org/wp-content/uploads/2023/08/MBCGA-Conference-Landing-Page-Image-copy.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221020T100000
DTEND;TZID=America/New_York:20221020T180000
DTSTAMP:20260417T102333
CREATED:20220723T133317Z
LAST-MODIFIED:20221110T233427Z
UID:1948-1666260000-1666288800@mbcglobalalliance.org
SUMMARY:MBCGA Annual Conference
DESCRIPTION:The Annual Male Breast Cancer Global Alliance Conference brings together male survivors\, their families\, friends and supporters for a “virtual” day of sharing\, learning and camaraderie. Medical professionals and organizations from all over the world also participate to impart the latest information on research and clinical trials\, and answer questions one-on-one. The conference\, which focuses on increasing awareness and education about breast cancer in men\, offers an impressive line-up of speakers (still in formation) including top medical professionals and leading experts from the breast cancer research and oncology fields. \n2022 Conference Speakers:\n																										 \nJohn Boyages\, AM\, Radiation Oncologist\, Icon Cancer Centre Sydney Adventist Hospital; Chair\, Icon National Breast Interest Group; Professor of Medicine\, ANU Medical School\, ANU College of Health and Medicine; Honorary Professor and Found Director\, ALERT Lymphodema Program; Author\, Taking Control series of patient books on breast cancer\, male breast cancer\, DCIS\, and cancer & vaccinations (Sydney\, Australia) \nRead more \n																										 \nBen H. Park\, MD\, PhD\, Professor of Medicine\, Associate Director for Translational Research\, Co-Leader Breast Cancer Program\, and Director for Precision Oncology at Vanderbilt University Medical Center (Nashville\, TN) \nRead more \n												\n		David Brenin\, MD\, FACS\, M.C. Wilhelm Professor in Diseases of the Breast and Chief of the Division of Breast and Melanoma Surgery\, in the department of surgery at The University of Virginia School of Medicine  (Charlottesville\, Virginia)\n\nRead more\nDavid R. Brenin\, MD\, FACS – 2022 MBCGA Conference Presentation\n																										 \nJosé Pablo Leone\, MD\, Director for Breast Cancer in Men at Dana-Farber Cancer Institute (Boston\, MA) and Assistant Professor of Medicine\, Harvard Medical School \nRead more \n																										 \nKathryn J. Ruddy\, MD\, Professor of Oncology (with a specialty in male breast cancer) and Consultant for the Division of Medical Oncology at the Mayo Clinic (Rochester\, MN) \nRead more \nBreakout sessions will also be part of the agenda\, providing opportunities for moderated discussions on key topics including Metastatic Breast Cancer\, Genetics & Male Breast Cancer\, Caregivers\, and Managing Treatment Side Effects. \nALL are welcome to attend our 2022 MBCGA Virtual Conference free of charge. However\, we would be extremely grateful if you would consider making a donation (no amount is too small!) to help us continue bringing you the most up-to-date information on breast cancer in men\, advances in research and treatments\, and opportunities for clinical trials. Thank you—in advance—for your support! \n			\n						Register\n					\n		\n\n\n    \n        \n        \n        \n        \n        \n        \n        \n    \n\n\n		 \nWe invite you to become an MBCGA Conference Sponsor\nAs an MBCGA Conference Sponsor\, your support will help us continue providing help and support to those who have been diagnosed. Our Annual Conference is an integral part of our ongoing efforts to provide education\, support and opportunities for men with breast cancer\, and their families and caregivers\, to connect with others who have experienced the “male breast cancer journey\,” and interact with medical professionals and researchers from all over the world. \nDownload our 2022 Annual Conference Sponsorship Brochure for more information on how YOU can help!
URL:https://mbcglobalalliance.org/event/mbcga-annual-conference/
ATTACH;FMTTYPE=image/jpeg:https://mbcglobalalliance.org/wp-content/uploads/2022/07/MBCGA-Conference-Landing-Page-Image-with-border.jpg
END:VEVENT
END:VCALENDAR